Global Hemophilia Therapeutics Market Research Report 2022

SKU ID : QYR-21348588 | Publishing Date : 18-Jul-2022 | No. of pages : 80

Request a free Sample

Detailed TOC of Global Hemophilia Therapeutics Market Research Report 2022

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Hemophilia Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Hemophilia A
        1.2.3 Hemophilia B
        1.2.4 Hemophilia C
    1.3 Market by Application
        1.3.1 Global Hemophilia Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Ambulatory Surgical Centers
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Hemophilia Therapeutics Market Perspective (2017-2028)
    2.2 Hemophilia Therapeutics Growth Trends by Region
        2.2.1 Hemophilia Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Hemophilia Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Hemophilia Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Hemophilia Therapeutics Market Dynamics
        2.3.1 Hemophilia Therapeutics Industry Trends
        2.3.2 Hemophilia Therapeutics Market Drivers
        2.3.3 Hemophilia Therapeutics Market Challenges
        2.3.4 Hemophilia Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Hemophilia Therapeutics Players by Revenue
        3.1.1 Global Top Hemophilia Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Hemophilia Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Hemophilia Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Hemophilia Therapeutics Revenue
    3.4 Global Hemophilia Therapeutics Market Concentration Ratio
        3.4.1 Global Hemophilia Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Hemophilia Therapeutics Revenue in 2021
    3.5 Hemophilia Therapeutics Key Players Head office and Area Served
    3.6 Key Players Hemophilia Therapeutics Product Solution and Service
    3.7 Date of Enter into Hemophilia Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Hemophilia Therapeutics Breakdown Data by Type
    4.1 Global Hemophilia Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Hemophilia Therapeutics Forecasted Market Size by Type (2023-2028)
5 Hemophilia Therapeutics Breakdown Data by Application
    5.1 Global Hemophilia Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Hemophilia Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Hemophilia Therapeutics Market Size (2017-2028)
    6.2 North America Hemophilia Therapeutics Market Size by Country (2017-2022)
    6.3 North America Hemophilia Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Hemophilia Therapeutics Market Size (2017-2028)
    7.2 Europe Hemophilia Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Hemophilia Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Hemophilia Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Hemophilia Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Hemophilia Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Hemophilia Therapeutics Market Size (2017-2028)
    9.2 Latin America Hemophilia Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Hemophilia Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Hemophilia Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Hemophilia Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Hemophilia Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Bayer AG
        11.1.1 Bayer AG Company Detail
        11.1.2 Bayer AG Business Overview
        11.1.3 Bayer AG Hemophilia Therapeutics Introduction
        11.1.4 Bayer AG Revenue in Hemophilia Therapeutics Business (2017-2022)
        11.1.5 Bayer AG Recent Development
    11.2 Pfizer, Inc.
        11.2.1 Pfizer, Inc. Company Detail
        11.2.2 Pfizer, Inc. Business Overview
        11.2.3 Pfizer, Inc. Hemophilia Therapeutics Introduction
        11.2.4 Pfizer, Inc. Revenue in Hemophilia Therapeutics Business (2017-2022)
        11.2.5 Pfizer, Inc. Recent Development
    11.3 Novo Nordisk A/S
        11.3.1 Novo Nordisk A/S Company Detail
        11.3.2 Novo Nordisk A/S Business Overview
        11.3.3 Novo Nordisk A/S Hemophilia Therapeutics Introduction
        11.3.4 Novo Nordisk A/S Revenue in Hemophilia Therapeutics Business (2017-2022)
        11.3.5 Novo Nordisk A/S Recent Development
    11.4 Baxter International Inc.
        11.4.1 Baxter International Inc. Company Detail
        11.4.2 Baxter International Inc. Business Overview
        11.4.3 Baxter International Inc. Hemophilia Therapeutics Introduction
        11.4.4 Baxter International Inc. Revenue in Hemophilia Therapeutics Business (2017-2022)
        11.4.5 Baxter International Inc. Recent Development
    11.5 Biogen Idec, Inc.
        11.5.1 Biogen Idec, Inc. Company Detail
        11.5.2 Biogen Idec, Inc. Business Overview
        11.5.3 Biogen Idec, Inc. Hemophilia Therapeutics Introduction
        11.5.4 Biogen Idec, Inc. Revenue in Hemophilia Therapeutics Business (2017-2022)
        11.5.5 Biogen Idec, Inc. Recent Development
    11.6 Genetics Institute
        11.6.1 Genetics Institute Company Detail
        11.6.2 Genetics Institute Business Overview
        11.6.3 Genetics Institute Hemophilia Therapeutics Introduction
        11.6.4 Genetics Institute Revenue in Hemophilia Therapeutics Business (2017-2022)
        11.6.5 Genetics Institute Recent Development
    11.7 Alpha Therapeutics Corporation
        11.7.1 Alpha Therapeutics Corporation Company Detail
        11.7.2 Alpha Therapeutics Corporation Business Overview
        11.7.3 Alpha Therapeutics Corporation Hemophilia Therapeutics Introduction
        11.7.4 Alpha Therapeutics Corporation Revenue in Hemophilia Therapeutics Business (2017-2022)
        11.7.5 Alpha Therapeutics Corporation Recent Development
    11.8 Expression Therapeutics
        11.8.1 Expression Therapeutics Company Detail
        11.8.2 Expression Therapeutics Business Overview
        11.8.3 Expression Therapeutics Hemophilia Therapeutics Introduction
        11.8.4 Expression Therapeutics Revenue in Hemophilia Therapeutics Business (2017-2022)
        11.8.5 Expression Therapeutics Recent Development
    11.9 Swedish Orphan Biovitrum AB.
        11.9.1 Swedish Orphan Biovitrum AB. Company Detail
        11.9.2 Swedish Orphan Biovitrum AB. Business Overview
        11.9.3 Swedish Orphan Biovitrum AB. Hemophilia Therapeutics Introduction
        11.9.4 Swedish Orphan Biovitrum AB. Revenue in Hemophilia Therapeutics Business (2017-2022)
        11.9.5 Swedish Orphan Biovitrum AB. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global Hemophilia Therapeutics Market Research Report 2022

List of Tables
    Table 1. Global Hemophilia Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Hemophilia A
    Table 3. Key Players of Hemophilia B
    Table 4. Key Players of Hemophilia C
    Table 5. Global Hemophilia Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Hemophilia Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Hemophilia Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Hemophilia Therapeutics Market Share by Region (2017-2022)
    Table 9. Global Hemophilia Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Hemophilia Therapeutics Market Share by Region (2023-2028)
    Table 11. Hemophilia Therapeutics Market Trends
    Table 12. Hemophilia Therapeutics Market Drivers
    Table 13. Hemophilia Therapeutics Market Challenges
    Table 14. Hemophilia Therapeutics Market Restraints
    Table 15. Global Hemophilia Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Hemophilia Therapeutics Market Share by Players (2017-2022)
    Table 17. Global Top Hemophilia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophilia Therapeutics as of 2021)
    Table 18. Ranking of Global Top Hemophilia Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Hemophilia Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Hemophilia Therapeutics Product Solution and Service
    Table 22. Date of Enter into Hemophilia Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Hemophilia Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Hemophilia Therapeutics Revenue Market Share by Type (2017-2022)
    Table 26. Global Hemophilia Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Hemophilia Therapeutics Revenue Market Share by Type (2023-2028)
    Table 28. Global Hemophilia Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Hemophilia Therapeutics Revenue Market Share by Application (2017-2022)
    Table 30. Global Hemophilia Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Hemophilia Therapeutics Revenue Market Share by Application (2023-2028)
    Table 32. North America Hemophilia Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Hemophilia Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Hemophilia Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Hemophilia Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Hemophilia Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Hemophilia Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Hemophilia Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Hemophilia Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Hemophilia Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Hemophilia Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Bayer AG Company Detail
    Table 43. Bayer AG Business Overview
    Table 44. Bayer AG Hemophilia Therapeutics Product
    Table 45. Bayer AG Revenue in Hemophilia Therapeutics Business (2017-2022) & (US$ Million)
    Table 46. Bayer AG Recent Development
    Table 47. Pfizer, Inc. Company Detail
    Table 48. Pfizer, Inc. Business Overview
    Table 49. Pfizer, Inc. Hemophilia Therapeutics Product
    Table 50. Pfizer, Inc. Revenue in Hemophilia Therapeutics Business (2017-2022) & (US$ Million)
    Table 51. Pfizer, Inc. Recent Development
    Table 52. Novo Nordisk A/S Company Detail
    Table 53. Novo Nordisk A/S Business Overview
    Table 54. Novo Nordisk A/S Hemophilia Therapeutics Product
    Table 55. Novo Nordisk A/S Revenue in Hemophilia Therapeutics Business (2017-2022) & (US$ Million)
    Table 56. Novo Nordisk A/S Recent Development
    Table 57. Baxter International Inc. Company Detail
    Table 58. Baxter International Inc. Business Overview
    Table 59. Baxter International Inc. Hemophilia Therapeutics Product
    Table 60. Baxter International Inc. Revenue in Hemophilia Therapeutics Business (2017-2022) & (US$ Million)
    Table 61. Baxter International Inc. Recent Development
    Table 62. Biogen Idec, Inc. Company Detail
    Table 63. Biogen Idec, Inc. Business Overview
    Table 64. Biogen Idec, Inc. Hemophilia Therapeutics Product
    Table 65. Biogen Idec, Inc. Revenue in Hemophilia Therapeutics Business (2017-2022) & (US$ Million)
    Table 66. Biogen Idec, Inc. Recent Development
    Table 67. Genetics Institute Company Detail
    Table 68. Genetics Institute Business Overview
    Table 69. Genetics Institute Hemophilia Therapeutics Product
    Table 70. Genetics Institute Revenue in Hemophilia Therapeutics Business (2017-2022) & (US$ Million)
    Table 71. Genetics Institute Recent Development
    Table 72. Alpha Therapeutics Corporation Company Detail
    Table 73. Alpha Therapeutics Corporation Business Overview
    Table 74. Alpha Therapeutics Corporation Hemophilia Therapeutics Product
    Table 75. Alpha Therapeutics Corporation Revenue in Hemophilia Therapeutics Business (2017-2022) & (US$ Million)
    Table 76. Alpha Therapeutics Corporation Recent Development
    Table 77. Expression Therapeutics Company Detail
    Table 78. Expression Therapeutics Business Overview
    Table 79. Expression Therapeutics Hemophilia Therapeutics Product
    Table 80. Expression Therapeutics Revenue in Hemophilia Therapeutics Business (2017-2022) & (US$ Million)
    Table 81. Expression Therapeutics Recent Development
    Table 82. Swedish Orphan Biovitrum AB. Company Detail
    Table 83. Swedish Orphan Biovitrum AB. Business Overview
    Table 84. Swedish Orphan Biovitrum AB. Hemophilia Therapeutics Product
    Table 85. Swedish Orphan Biovitrum AB. Revenue in Hemophilia Therapeutics Business (2017-2022) & (US$ Million)
    Table 86. Swedish Orphan Biovitrum AB. Recent Development
    Table 87. Research Programs/Design for This Report
    Table 88. Key Data Information from Secondary Sources
    Table 89. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Hemophilia Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Hemophilia A Features
    Figure 3. Hemophilia B Features
    Figure 4. Hemophilia C Features
    Figure 5. Global Hemophilia Therapeutics Market Share by Application in 2021 & 2028
    Figure 6. Hospitals Case Studies
    Figure 7. Clinics Case Studies
    Figure 8. Ambulatory Surgical Centers Case Studies
    Figure 9. Hemophilia Therapeutics Report Years Considered
    Figure 10. Global Hemophilia Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Hemophilia Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Hemophilia Therapeutics Market Share by Region: 2021 VS 2028
    Figure 13. Global Hemophilia Therapeutics Market Share by Players in 2021
    Figure 14. Global Top Hemophilia Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophilia Therapeutics as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Hemophilia Therapeutics Revenue in 2021
    Figure 16. North America Hemophilia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Hemophilia Therapeutics Market Share by Country (2017-2028)
    Figure 18. United States Hemophilia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Hemophilia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Hemophilia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Hemophilia Therapeutics Market Share by Country (2017-2028)
    Figure 22. Germany Hemophilia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Hemophilia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Hemophilia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Hemophilia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Hemophilia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Hemophilia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Hemophilia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Hemophilia Therapeutics Market Share by Region (2017-2028)
    Figure 30. China Hemophilia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Hemophilia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Hemophilia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Hemophilia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Hemophilia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Hemophilia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Hemophilia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Hemophilia Therapeutics Market Share by Country (2017-2028)
    Figure 38. Mexico Hemophilia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Hemophilia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Hemophilia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Hemophilia Therapeutics Market Share by Country (2017-2028)
    Figure 42. Turkey Hemophilia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Hemophilia Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Bayer AG Revenue Growth Rate in Hemophilia Therapeutics Business (2017-2022)
    Figure 45. Pfizer, Inc. Revenue Growth Rate in Hemophilia Therapeutics Business (2017-2022)
    Figure 46. Novo Nordisk A/S Revenue Growth Rate in Hemophilia Therapeutics Business (2017-2022)
    Figure 47. Baxter International Inc. Revenue Growth Rate in Hemophilia Therapeutics Business (2017-2022)
    Figure 48. Biogen Idec, Inc. Revenue Growth Rate in Hemophilia Therapeutics Business (2017-2022)
    Figure 49. Genetics Institute Revenue Growth Rate in Hemophilia Therapeutics Business (2017-2022)
    Figure 50. Alpha Therapeutics Corporation Revenue Growth Rate in Hemophilia Therapeutics Business (2017-2022)
    Figure 51. Expression Therapeutics Revenue Growth Rate in Hemophilia Therapeutics Business (2017-2022)
    Figure 52. Swedish Orphan Biovitrum AB. Revenue Growth Rate in Hemophilia Therapeutics Business (2017-2022)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed

Keyplayers in Global Hemophilia Therapeutics Market Research Report 2022

Bayer AG
Pfizer, Inc.
Novo Nordisk A/S
Baxter International Inc.
Biogen Idec, Inc.
Genetics Institute
Alpha Therapeutics Corporation
Expression Therapeutics
Swedish Orphan Biovitrum AB.